181 related articles for article (PubMed ID: 16377694)
1. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs.
Ren H; Liu J
Antimicrob Agents Chemother; 2006 Jan; 50(1):250-5. PubMed ID: 16377694
[TBL] [Abstract][Full Text] [Related]
2. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
3. Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues.
Campen RL; Ackerley DF; Cook GM; O'Toole RF
Tuberculosis (Edinb); 2015 Jul; 95(4):432-9. PubMed ID: 25936537
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a major Zn(II) resistance determinant of Mycobacterium smegmatis.
Grover A; Sharma R
J Bacteriol; 2006 Oct; 188(19):7026-32. PubMed ID: 16980506
[TBL] [Abstract][Full Text] [Related]
5. Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.
Lu T; Zhao X; Li X; Hansen G; Blondeau J; Drlica K
J Antimicrob Chemother; 2003 Jul; 52(1):61-4. PubMed ID: 12805268
[TBL] [Abstract][Full Text] [Related]
6. Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene.
Pelchovich G; Zhuravlev A; Gophna U
Int J Antimicrob Agents; 2013 Aug; 42(2):129-32. PubMed ID: 23664678
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis.
Stephan J; Mailaender C; Etienne G; Daffé M; Niederweis M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4163-70. PubMed ID: 15504836
[TBL] [Abstract][Full Text] [Related]
8. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
Alexander DC; Jones JR; Liu J
Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
[TBL] [Abstract][Full Text] [Related]
9. The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis.
Castañeda-García A; Do TT; Blázquez J
J Antimicrob Chemother; 2011 Jul; 66(7):1489-98. PubMed ID: 21613307
[TBL] [Abstract][Full Text] [Related]
10. Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics.
Rawat M; Newton GL; Ko M; Martinez GJ; Fahey RC; Av-Gay Y
Antimicrob Agents Chemother; 2002 Nov; 46(11):3348-55. PubMed ID: 12384335
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
[TBL] [Abstract][Full Text] [Related]
12. S-Nitrosoglutathione cytotoxicity to Mycobacterium smegmatis and its use to isolate stationary phase survival mutants.
Smeulders MJ; Keer J; Gray KM; Williams HD
FEMS Microbiol Lett; 2004 Oct; 239(2):221-8. PubMed ID: 15476969
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel metronidazole-inducible genes in Mycobacterium smegmatis using a customized amplification library.
Kim SY; Shin SJ; Song CH; Jo EK; Kim HJ; Park JK
FEMS Microbiol Lett; 2008 May; 282(2):282-9. PubMed ID: 18373646
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis.
Newton GL; Unson MD; Anderberg SJ; Aguilera JA; Oh NN; delCardayre SB; Av-Gay Y; Fahey RC
Biochem Biophys Res Commun; 1999 Feb; 255(2):239-44. PubMed ID: 10049692
[TBL] [Abstract][Full Text] [Related]
15. [The effect of liposomes on the growth and sensitivity of Mycobacterium smegmatis to isoniazide].
Troshkina OA; Salina EG; Sorokoumova GM; Kaprel'iants AS; Selishcheva AA
Prikl Biokhim Mikrobiol; 2007; 43(1):47-52. PubMed ID: 17345858
[TBL] [Abstract][Full Text] [Related]
16. A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis.
Carrère-Kremer S; Blaise M; Singh VK; Alibaud L; Tuaillon E; Halloum I; van de Weerd R; Guérardel Y; Drancourt M; Takiff H; Geurtsen J; Kremer L
Mol Microbiol; 2015 Jun; 96(5):1085-102. PubMed ID: 25754266
[TBL] [Abstract][Full Text] [Related]
17. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
[TBL] [Abstract][Full Text] [Related]
18. Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket.
Long KS; Poehlsgaard J; Hansen LH; Hobbie SN; Böttger EC; Vester B
Mol Microbiol; 2009 Mar; 71(5):1218-27. PubMed ID: 19154331
[TBL] [Abstract][Full Text] [Related]
19. Role of porins for uptake of antibiotics by Mycobacterium smegmatis.
Danilchanka O; Pavlenok M; Niederweis M
Antimicrob Agents Chemother; 2008 Sep; 52(9):3127-34. PubMed ID: 18559650
[TBL] [Abstract][Full Text] [Related]
20. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
